88 related articles for article (PubMed ID: 77823)
21. [Therapy of malignant lymphomas].
Huber H; Gattringer C; Lechleitner M; Gyenes T; Frommhold H; Brittinger G; Braunsteiner H
Wien Klin Wochenschr; 1983 Feb; 95(4):93-112. PubMed ID: 6342274
[TBL] [Abstract][Full Text] [Related]
22. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
23. Results of treating stage III and IV malignant non-Hodgkin's lymphomas (NHL).
Jahn H; Ruffert K; Syrbe G; Kühn R; Jorke D
Arch Geschwulstforsch; 1988; 58(2):113-20. PubMed ID: 2454087
[TBL] [Abstract][Full Text] [Related]
24. [Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
Viollier AF; Senn HJ
Schweiz Med Wochenschr; 1976 May; 106(22):730-42. PubMed ID: 996491
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.
Lee MY; Tan TD; Feng AC; Liu MC
Am J Hematol; 2006 Aug; 81(8):568-75. PubMed ID: 16823825
[TBL] [Abstract][Full Text] [Related]
26. [Bone marrow biopsy in non-Hodgkin's lymphoma: experience with 259 samples].
Hernández Nieto L; Hernández García MT; González Brito G; Brito Barroso ML; Marsa Vila L; Chavez MI
Sangre (Barc); 1989 Aug; 34(4):271-7. PubMed ID: 2772780
[TBL] [Abstract][Full Text] [Related]
27. [Experience with results of treatment of non-Hodgkin's lymphoma].
Gurzó M; Dobos K; Bérczi M; Varga G; Kelényi G
Orv Hetil; 1992 May; 133(18):1091-7. PubMed ID: 1579348
[TBL] [Abstract][Full Text] [Related]
28. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ogawa M; Tominaga S; Tsugane S; Minato K
Jpn J Clin Oncol; 1988 Jun; 18(2):113-24. PubMed ID: 3379782
[TBL] [Abstract][Full Text] [Related]
29. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
30. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
31. [Clinical features of malignant follicular non-Hodgkin's lymphoma (author's transl)].
Delbrück H; Wetter O; Schmidt CG; Weichert C; Linder KH
Dtsch Med Wochenschr; 1977 Sep; 102(36):1273-9. PubMed ID: 332479
[TBL] [Abstract][Full Text] [Related]
32. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
34. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.
Atra A; Imeson JD; Hobson R; Gerrard M; Hann IM; Eden OB; Carter RL; Pinkerton CR
Br J Cancer; 2000 Apr; 82(8):1396-402. PubMed ID: 10780517
[TBL] [Abstract][Full Text] [Related]
35. [Primary non-Hodgkin lymphoma of the stomach. A review with special reference to the MALT concept].
Cogliatti SB; Schmid U
Schweiz Med Wochenschr; 1994 Oct; 124(40):1764-74. PubMed ID: 7939542
[TBL] [Abstract][Full Text] [Related]
36. Outline of a prospective multicentric study on the clinical significance of the Kiel classification of non-Hodgkin's lymphomas.
Brittinger G
Recent Results Cancer Res; 1978; 65():197-202. PubMed ID: 746247
[TBL] [Abstract][Full Text] [Related]
37. [Sequential chemotherapy of malignant non-Hodgkin's lymphoma of high degree of malignancy in stages III and IV].
Mitrou PS; Fischer M; Bergmann L; Hübner K
Onkologie; 1982 Oct; 5(5):222-7. PubMed ID: 6760023
[TBL] [Abstract][Full Text] [Related]
38. Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.
Lister TA; Cullen MH; Beard ME; Brearley RL; Whitehouse JM; Wrigley PF; Stansfeld AG; Sutcliffe SB; Malpas JS; Crowther D
Br Med J; 1978 Mar; 1(6112):533-7. PubMed ID: 630211
[TBL] [Abstract][Full Text] [Related]
39. Clinico-pathological correlations in the Kiel classification of non-Hodgkin's lymphomata in children.
Garwicz S; Landberg T; Lindberg LG; Akerman M
Scand J Haematol; 1978 Feb; 20(2):171-80. PubMed ID: 635468
[TBL] [Abstract][Full Text] [Related]
40. [On the dissemination of B-cell non-Hodgkin lymphomas at the time of diagnosis].
Pap T; Vogt U; Waldinger K; Kelényi G
Zentralbl Allg Pathol; 1982; 126(3-4):321-6. PubMed ID: 7148187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
